News

In the news | Nov. 20, 2024

Norstella recognized as company of the year in the 2024 BIG Awards for Business

Norstella is pleased to announce that the Business Intelligence Group has selected the company as a winner in its hotly contested "Company of the Year" category. This recognition, part of the broader 2024 BIG Awards for Business, celebrates those companies, products, and leaders making a significant impact by reshaping their industries and setting new standards for success. For Norstella, it signifies the considerable progress we are making against our mission to to smooth the path to lifesaving therapies for patients and providers. Read more

Press Releases | Oct. 08, 2024

Norstella introduces NorstellaLinQ, the biopharma industry’s first fully integrated data asset

NEW YORK – October 8, 2024 - Today, Norstella unveiled NorstellaLinQ, the biopharma industry’s first and only fully integrated data asset combining both real-world data (RWD) — including open and closed claims, lab results and structured and unstructured electronic medical records (EMR) — with Norstella’s proprietary forecasting, clinical, regulatory, payer, coverage and commercial intelligence data. Read more

Press Releases | Sep. 05, 2024

Panalgo introduces IHD Cloud, a transformative solution for RWE data and analytics centralization

Boston, MA - Sept. 5, 2024 - Panalgo, a Norstella company committed to revolutionizing healthcare data analytics, is announcing the launch of IHD Cloud, a cutting-edge solution that will transform how organizations manage and use real-world data (RWD) to generate real-world evidence (RWE). Powered by Amazon Web Services (AWS), IHD Cloud offers a scalable and flexible platform to centralize data and technology, driving meaningful and timely insights for any evidence generating organization. Read more

Press Releases | Aug. 13, 2024

In a first for pharma, Citeline SmartSolutions take AI to new levels, optimizing clinical trial planning and site selection

NEW YORK – Aug. 13, 2024 – Citeline, a leader in intelligence solutions for the life sciences industry, has launched two new products — Protocol SmartDesign and Investigator SmartSelect — in its Citeline SmartSolutions suite accelerating the path from pipeline to patient. Citeline SmartSolutions, an industry first, enables users to design and conduct more predictable trials by connecting the robust data assets already trusted by over 3,000 Citeline customers. Read more

Press Releases | Jun. 17, 2024

Atropos Health partners with Norstella to expand the Atropos Evidence™ Network and structured clinical trial intelligence

BOSTON – June 17, 2024 – Norstella, one of the largest global pharma intelligence solution providers, today announced a strategic partnership with Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care. This collaboration follows Atropos Health’s recent announcement of $33 million in Series B funding, furthering its expansion into life sciences. Read more

Press Releases | Jan. 10, 2024

Evaluate, a Norstella company, announces acquisition of J+D Forecasting

January 8, 2024, London, UK and Boston, MA – Evaluate, a Norstella company, announced today the acquisition of J+D Forecasting, a leading provider of forecasting solutions for the pharmaceutical industry. Read more

Press Releases | Dec. 04, 2023

MMIT wins Titan Health Award for healthcare innovation

December 4, 2023, Yardley, PA – MMIT, a Norstella company and the trusted go-to-market partner for overcoming barriers to patient access, is excited to announce that its Patient Access Analytics solution has won a Titan Health Award, which celebrates and recognizes extraordinary achievements in healthcare advertising and marketing. Read more

Press Releases | May. 16, 2023

Industry veteran Fred Hassan joins the board of Norstella

Norstella, a leader in helping patients gain access to life-saving therapies by navigating the complexities at each step of the drug development life cycle, is pleased to announce that Fred Hassan has joined its board of directors. Hassan brings a wealth of experience and expertise in healthcare, having served as CEO of several major pharmaceutical companies and as a board member of numerous healthcare organizations. He has held senior leadership roles at some of the world's most prominent organizations, including Schering-Plough, Pharmacia Corporation, and Bausch & Lomb. Read more

Press Releases | Apr. 04, 2023

TriNetX and Clinerion unite as TriNetX and Norstella announce strategic partnership

Cambridge, MA, April 4, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of novel therapies, and Norstella, the leading pharmaceuticals solutions provider, today announced a multi-faceted strategic partnership. As part of this exciting partnership, TriNetX will acquire Norstella’s Clinerion Ltd. subsidiary, expanding the growth of the world’s leading research network for real world data (RWD). Read more

Press Releases | Mar. 30, 2023

Citeline launches TrialScope intelligence, meeting the growing complexities of clinical trial disclosure

Clinical trial disclosure compliance is challenging, whether a sponsor is registering five trials or 500 trials. Compounding the complexity is the fact that no global standards exist for disclosure. With ever-changing global regulations, new requirements on the rise and the threat of monetary penalties, study sponsors are feeling the pressure to maintain compliance, minimize risk and safeguard their brand reputation. Read more

In the news | Mar. 07, 2023

How robust data technology is transforming the design and execution of viable clinical trials

While incorporating real-world data (RWD) and real-world evidence (RWE) across the drug development lifecycle is getting a lot of attention, the application of such insights gleaned from rigorous analysis to the design and execution of clinical trials has yet to be widely adopted, despite its potential to address some of these persistent challenges. Read more

In the news | Jan. 08, 2023

What do you view as the most disruptive or transformational technology or development on the horizon?

Norstella CEO, Mike Gallup, weighs in on the most disruptive / transformational technology on the horizon in a recent pharma’s almanac piece. “As regulators and payers look for new information to guide their decision-making, real-world data and evidence are poised to play a transformative role in not only getting drugs to market quickly, but also ensuring that patients can access them.” Read more

See More News

Norstella News